WASHINGTON (AP) -- The Food and Drug Administration has approved a breakthrough cancer medication from Bristol-Myers Squibb Co. that researchers have heralded as the first drug to prolong the lives of patients with melanoma....
By MATTHEW PERRONE, Associated Press: Health
Fri, 03/25/2011 - 10:43am